[1]ClaudiaChiodoni, SabinaSangaletti, ClaudioTripodo& Mario P Colom- bo.The ins and outs of osteopontin [J].OncoImmunology, 2015, 4(3);e978711. [2]HussleinH, HaiderS, MeinhardtG, etal.Expression,regulation and functional characterization of matrix metalloproteinase-3 of human trophobla- stPlac[J].enta, 2009, 30(3):284-291 [3]RittlingSR, Chambers A Fetal.Role of osteopontin in tumor progression [J][J].Br J Cancer, 2004, 90(10):1877-1881 [4]RudAK, BoyeK, Oijordsbakken M, Lund-Iversen M, Halvorsen AR.Osteopontin is a prognostic biomarker in non-small cell lung cancer[J].BMC Cancer, 2013, 13:540. . [5]Song J, GeZ, YangX, LuoQ, WangC, You H.Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin[J].Cancer Lett, 2015, 356(2 )Pt B :713-20. [6]胡涂,曾乐平.在肿瘤发生发展中作用的新进展[J].肿瘤药学, 2013, 3(3):166-171 [7]Shuman Moss LA, Jensen-TaubmanS, Stetler-Stevenson WGetal.Matrix metalloproteinases: changing roles in tumor progression and metastasis[J].Am J Pathol, 2012, 181(6):1895-9 [8]Rodriguez DE, Thula-Mata T, ToroEJ, YehYW, HoltC, HollidayLS, GowerLB.Multifunctional role of ost- eopontin in directing intrafibrillar mineralization of collagen and activation of osteoclast[J].ActaBioma- ter.2014, 10(1) :494-507. [9]Tang X, LiJ, YuB, SuL, YuY, YanM, LiuB, Zhu Z.Osteopontin splice variants differentially exert clinicopathological features and biological functions in gastric cancer[J].Int J Biol Sci.2013, 9(1 ):55-66. [10]Abu El-AsrarAM, Imtiaz Nawaz M, KangaveD, SiddiqueiMM, Geboes K .Osteopontin and other regulators of angiogenesis and fibrogenesis in the vitreous from patients with proliferative vitreoretinaldisorders[J].Mediators Inflamm.2012, 2012 :493043. [11] BramwellVH, TuckAB, ChapmanJA, AnborghPH, Postenka CO, Al-Katib W.Assessment of oste- opontin in early breast cancer: correlative study in a randomised clinical trialBreast [J].Cancer Res 2014, 16(1) :8. [12]Jin Y, Chen JN, Feng ZY, Zhang ZG, Fan WZ, Wang Y, Li JP.OPN and alphavbeta3 expression arepredictors of disease severity and worse prognosis in hepatocellularcarcinoma[J].PLoSOne.2014, 9(2) :e87930. [13]EL-TANANIMK, AMPBELLFC, KURISETTYV, etal.The regulation and role of osteopontin in malignant transformation and cancer[ J][J].Cytokine Growth Factor Rev, 2006, 17(6):463-474 [14]Da Costa AN, PlymothA, Santos-Silva D, Ortiz -CuaranS, CameyS, Guilloreau P.Osteopontin and latent-TGF beta binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular car- cinoma[J].Int J Cancer.2015, 136(1) :172-81. [15]Cao DX, LiZJ, JiangXO, LumYL, KhinE, LeeNP, WuGH, Luk JM.osteopontin as potential bio- marker and therapeutic target in gastric and liver cancers[J].WorldJ Gastroenterl.2012, 18(30):3923-30. [16]McCawleyLJ, WrightJ, LaFleurBJ, CrawfordHC, MatrisianLM.keratinocyte expression of mmp3 enhances differentiation and prevents tumor establishment[J] .Am J Pathol.2008, 173(5) :1528-1539. [17]Dey S, Stalin S, Gupta A, et al.Matrix metalloproteinase 3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population[J].MolCarcinog, 2012, 51(S1):E42-E53 [18]FedarkoNS, Jain A, Karadag A, etal.Three small integrin bind- ingLigandN-linked glycoproteins (SIBLINGs) bind and activate specific matrixmetalloproteinases[J].FASEBJ, 2004, 18:734 -736. [19] Fedarko NS, Jain A, Karadag A, Fisher LW.Three small integrin binding ligand N-linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinases[J].FASEBJ, 2004, 18:734–6. [20]Chen HJ, Wang JJ.The structure and regulation mechanism of matrix metalloproteinase[J].Foreign Med Sci(Cancer Section), 2001, 28(1):20-23 [21]McColgan P, Sharma P.Polymorphisms of matrix metalloproteinases 1,2,3 and 9 and susceptibility to lung,breast and colorectal cancer in over 30,000 subjects[J].Int J Cancer, 2009, 125(6):1473-1478 [22]Fakhoury HM, Noureddine S, Tamim H, et al.Association of MMP3-1171(5A6A) polymorphism with lung cancer in Lebanon[J].Genet Test Mol Biomarkers, 2012, 16(8):988-990 [23]Dey S, Stalin S, Gupta A, et al.Matrix metalloproteinase 3 gene promoter polymorphisms and their haplotypes are associated with gastric cancer risk in eastern Indian population[J].MolCarcinog, 2012, 51(S1):E42-E53 [24]赵岭, 岭吴春平, 李景光.骨桥蛋白和基质金属蛋白酶-3、10在结肠癌组织中的表达及意义[J].临床和实验医学杂志, 2017, (3):1671-4695. [25]KonS, NakayamaY, MatsumotoN, ItoK, KanayamaM, KimuraC, KouroH, AshitomiD, MatsudaT, Uede T.A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C- terminal fragment of MMP-3/7- cleaved osteopontin as a novel ligand for alpha9beta1 integrin is involved in the anti-type II collagen antibody-induced arthritis[J].PLoS One.2014, 9(12 ):e116210 . . [26]Liu JLiuQ, WanY, ZhaoZ, YuH, LuoH, Tang Z.Osteopontin promotes the progression of gastric cancer through the NF-kappaB pathway regulated by the MAPK and PI3K[J].Int J Oncol.2014, 45(1): 282-90. . [27]UhlmannME, GeorgievaM, SillM, LinnemannU, BergerMR.prognostic value of tumor progression- related gene expression in colorectal cancer patients [J].Cancer Res Clin Oncol.2012, 138(10) :1631-40
|